Labcorp Holdings
LABCORP HOLDINGS INC.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$14.0B
Operating marginCalculated
9.9%
Net assets to total assetsCalculated
46.9%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★☆☆position among all companies
9.9%
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
1.5%
Capital efficiency
★★★☆☆position among all companies
10.2%
Revenue and profit
Performance, financial position and capital allocation
Labcorp Holdings
Recent performance trends
Labcorp Holdings
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$13.1 billion | US$11.9 billion | US$12.2 billion | US$13.0 billion | US$14.0 billion |
| Operating income | US$3.0 billion | US$1.4 billion | US$0.7 billion | US$1.1 billion | US$1.4 billion |
| Net income | US$2.4 billion | US$1.3 billion | US$0.4 billion | US$0.7 billion | US$0.9 billion |
| Total assets | US$20.4 billion | US$20.2 billion | US$16.7 billion | US$18.4 billion | US$18.4 billion |
| Shareholders' equity | US$10.3 billion | US$10.1 billion | US$7.9 billion | US$8.1 billion | US$8.6 billion |
| Net cash provided by (used in) operating activities | US$3.1 billion | US$2.0 billion | US$1.3 billion | US$1.6 billion | US$1.6 billion |
| Net cash provided by (used in) investing activities | US$-0.9 billion | US$-1.7 billion | US$-1.2 billion | US$-1.4 billion | US$-1.2 billion |
| Net cash provided by (used in) financing activities | US$-2.1 billion | US$-1.3 billion | US$-59.30 million | US$0.8 billion | US$-1.5 billion |
| Cash and cash equivalents | US$1.5 billion | US$0.3 billion | US$0.5 billion | US$1.5 billion | US$0.5 billion |
Revenue scale in the same industry
Labcorp Holdings
Health services: 20 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 HCA Healthcare US$75.6B
- 2 Tenet Healthcare US$21.3B
- 3 Universal Health Services US$17.4B
- 4 Labcorp HoldingsThis company US$14.0B
- 5 Davita US$13.6B
- 6 BrightSpring Health Services US$12.9B
- … 14 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.4 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-1.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-1.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$1.6 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.7 billion | Consolidated | Disclosed |
| Dividends paid | US$0.2 billion | Consolidated | Disclosed |
| Number of employees | 70,000 | Consolidated | Disclosed |
| Net assets | US$8.6 billion | Consolidated | Disclosed |
| Net sales | US$14.0 billion | Consolidated | Disclosed |
| Operating income | US$1.4 billion | Consolidated | Disclosed |
| Net income | US$0.9 billion | Consolidated | Disclosed |
| Total assets | US$18.4 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.5 billion | Consolidated | Disclosed |
| Operating margin | 9.9% | Consolidated | Calculated |
| Net assets to total assets | 46.9% | Consolidated | Calculated |
| Net margin | 6.3% | Consolidated | Calculated |
| Return on equity | 10.2% | Consolidated | Calculated |